Nutrition
James Swift · 29 Oct 2025 · 14 min read
Semaglutide and tirzepatide produce substantial weight loss, and trials show some of that is measured lean mass — which isn't the same thing as muscle. What the evidence actually supports, and how resistance training and nutrition fit in.
Large weight loss does not come entirely from fat, and that distinction gets lost in most of the conversation around GLP-1 medication.
For decades, "watch your weight" and BMI were treated as the main measure of health. Now, with powerful GLP-1 drugs like Ozempic, Wegovy, and Mounjaro — semaglutide and tirzepatide — becoming mainstream treatments, dramatic weight loss often gets celebrated as an unqualified win, full stop.
A patient loses 14 kg. Their BMI drops from "obese" to "overweight." On paper, they look healthier. Trials of semaglutide and tirzepatide show that a measurable proportion of that weight loss is lean mass, not fat. Lean mass is a body-composition measurement — it includes muscle, but it isn't the same thing as muscle, and not every kilogram of it lost is functional tissue you'd notice losing. Even so, without attention to nutrition and resistance training, some of what's lost is tissue that supports strength, bone loading and long-term physical function.
None of this means the medication is the problem. Significant weight loss commonly includes some lean-mass loss, whether it's achieved with medication or through diet and exercise alone — the evidence shows GLP-1-associated weight loss and lifestyle-only weight loss carry a broadly comparable proportional lean-mass cost. What differs is how much deliberate attention gets paid to protecting strength and function while the weight comes off.
The drugs are not the problem. The question is what happens to the rest of your body while the number on the scale goes down — and that question matters whichever route got you there.
Before we go further, there is something worth addressing. A growing number of personal trainers and fitness influencers have positioned themselves as aggressively anti-GLP-1. They frame these drugs as cheating, as laziness, as everything wrong with modern health culture. They post reels about how "real results come from hard work," and they treat anyone on Ozempic as though they have personally betrayed the sanctity of the squat rack.
This is not principled opposition. It is fear disguised as ethics.
The trainers most loudly opposed to GLP-1 drugs are, overwhelmingly, the ones whose entire business model rests on meal plan templates and motivational accountability. Their coaching consists of handing someone a PDF, telling them to eat chicken and broccoli, and yelling at them when they fall off the plan. When a drug removes the hunger that their "coaching" was supposedly managing, they become irrelevant. And they know it.
The correct position on GLP-1 drugs is not that they are good or bad. It is that they are powerful tools being deployed without adequate support. A trainer who understands progressive overload, body composition, and protein periodisation during a deficit has something genuinely useful to add alongside the prescribing clinician's own care.
The drugs handle appetite regulation. Coaching can support what's left: resistance training, general nutrition habits, and tracking the strength and functional capacity that determine whether this weight loss leaves someone more capable, not less.
The trainers screaming about Ozempic are telling you more about their business model than about your health.
Spend five minutes in any Ozempic, Wegovy, or Mounjaro forum online, and you will see the problem immediately. Thousands of people, often thrilled with their weight loss, asking the same desperate questions.
"I have lost 12 kg but I feel so weak. Is this normal?" "I can barely lift my shopping bags anymore." "My hair is falling out. Should I be eating more protein?" "I am eating 900 calories a day because I am just not hungry. Is that okay?" "Do I need to exercise on this medication, or will it work on its own?"
These are not stupid questions. These are legitimate concerns from people who were handed a prescription, told to weigh themselves weekly, and given very little explanation of what is actually happening to their body. They are navigating one of the most powerful weight loss interventions in medical history with little beyond a patient information leaflet and a Facebook group.
The responses they get are equally uninformed. Well-meaning people sharing their own experiences, none of which include proper nutritional guidance or training protocols, because none of them received that information either.
Nobody told them protein needs typically go up during rapid weight loss, or that trials of these drugs show a measurable proportion of the weight lost is lean mass, not fat. Nobody mentioned resistance training, bone density, or functional capacity. They were just told the drug would help them lose weight, and it has. That's real progress — but it isn't the whole picture.
Before we discuss what actually matters for your health, we need to address the metric everyone is obsessing over.
Body Mass Index was developed in the 1830s by a Belgian mathematician named Adolphe Quetelet. Not a doctor. Not a physiologist. A statistician trying to describe the "average man" for population studies. It was never intended to be used as a personal health assessment tool.
BMI is a ratio of your weight to your height squared. That is it. It has zero ability to distinguish between 10 kg of metabolically active muscle and 10 kg of adipose tissue. It cannot tell you where you store fat, and it certainly cannot tell you if you are carrying dangerous visceral fat around your organs or relatively benign subcutaneous fat. It knows nothing about your bone density, your muscle mass, your metabolic health, or your functional capacity.
A 90 kg man with 15% body fat and significant muscle mass is "overweight" according to BMI. A 70 kg woman with 35% body fat and minimal muscle is "healthy weight." The system is fundamentally broken. Yet it remains the primary metric doctors use to determine whether you need intervention.
This matters because the entire justification for prescribing weight loss interventions, whether drugs, diets, or surgery, rests on reducing that number. Not improving your body composition. Not increasing your muscle mass. Not protecting your bone density. Just making the number smaller.
GLP-1 receptor agonists like Ozempic and Wegovy (semaglutide) work by mimicking a hormone that regulates appetite and blood sugar; Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist with a related but distinct mechanism. They were originally developed for type 2 diabetes, and they are genuinely effective at improving insulin sensitivity and glycaemic control. They make you feel full faster, reduce hunger, slow gastric emptying, and help regulate blood sugar levels.
These are not trivial benefits. For someone struggling with insulin resistance, constant hunger, or difficulty managing their diabetes, these drugs can be genuinely life-changing. They address real physiological problems that diet and exercise alone sometimes cannot fix, especially in individuals with severe metabolic dysfunction.
The result is often significant weight loss, typically 10 to 15% of body weight within the first year. For many people, this weight loss improves cardiovascular markers, reduces joint stress, improves mobility, and genuinely enhances quality of life.
So what is the problem? The drugs themselves are not the issue. The issue is that patients are often prescribed these medications with very little guidance on body composition, protein needs, or the value of resistance training alongside them.
They are sent home with a prescription and told to come back in three months for a weigh-in, or worse, just told to fill out an online form and send in photos of themselves in underwear as proof of current weight.
Trials of semaglutide and tirzepatide show that a meaningful share of the weight lost — commonly cited in the range of roughly a quarter to over a third, depending on the drug and the study — is measured as lean mass rather than fat (1,2). Lean mass is a body-composition category that includes muscle along with other tissue and fluid; it is not a direct measure of skeletal muscle lost, and losing lean mass is not automatically the same as losing strength or function. Even so, it's a real signal that resistance training and adequate protein deserve deliberate attention during treatment, not an afterthought.
The catastrophic failure here is not the medication. It is that we are celebrating weight loss without any assessment of what was actually lost. Patients are weighing themselves daily, posting their scale victories online, and nobody is asking the critical question: was it fat, or was it muscle?
Imagine going to a mechanic and saying, "My car is too heavy, make it lighter." The mechanic removes 100 kg of weight and you celebrate. Then you discover he removed the engine, the suspension, and the braking system. The car is lighter, yes. It also does not work anymore.
This is what is happening when we focus exclusively on scale weight. We are removing essential components and celebrating the number without asking whether the system still functions.
Lean body mass is a body-composition category covering everything that isn't fat — muscle, bone, organs, body water. It's a useful proxy when you have nothing better, but it's a proxy, not a direct read on your muscle or your strength. Two people can lose the same amount of measured lean mass and end up in very different places depending on how much of it they protect through training and nutrition.
Body composition, the ratio of lean mass to fat mass, is what determines your actual health outcome. Two people can weigh exactly the same and have completely different health trajectories depending on their body composition. A person with high muscle mass and moderate fat is metabolically healthier, stronger, and more resilient than a person with low muscle mass and the same total weight.
Functional capacity is the real marker of health and independence. Can you carry your shopping? Can you get up from a chair without using your hands? Can you climb stairs without getting winded? The scale tells you none of this.
Bone density is living tissue that responds to mechanical stress through resistance training. Rapid weight loss without any resistance training is a plausible risk factor for bone density loss over time — another reason training belongs alongside the medication, not proof of what will happen to any one individual.
Metabolic health, including insulin sensitivity, blood sugar regulation, and cardiovascular markers, improves with fat loss but can actually worsen if you lose significant muscle mass because muscle is metabolically active tissue that helps regulate glucose.
None of these appear on your bathroom scale. None of these are captured by BMI. Yet these are the metrics that determine whether you are healthy or simply lighter.
When you lose weight without protecting lean body mass, here's what's actually at stake.
Working against sarcopenia, not adding to it. Sarcopenia is the age-related loss of muscle mass and strength. It's a natural part of ageing, but it can be slowed, managed, and partially reversed with resistance training and adequate nutrition. If significant weight loss happens without attention to either, you're starting your ongoing ageing trajectory from a lower baseline — which is a real reason to protect strength and function during treatment, not a reason to fear the medication itself.
Strength and fall risk. Muscle mass and strength are among the factors associated with fall risk in older adults, and falls are not minor — a hip fracture is a serious, sometimes life-altering event. That's an argument for building and keeping strength at any age, not a specific prediction about what will happen to you individually on this medication.
Poor recovery from illness. When you become ill or injured, your body relies on muscle tissue as a metabolic reserve. Muscle is metabolically active tissue that supports immune function, wound healing, and recovery. If you have already depleted your muscle mass through rapid weight loss, you have less reserve to draw on when you need it most.
Loss of independence. The ability to carry groceries, climb stairs, and get up from a chair without assistance are not trivial markers of quality of life. They are the difference between independence and dependence. Muscle mass is the foundation of functional capacity. When you lose it, you lose your autonomy.
Reduced movement and activity capacity. When you lose muscle mass, the real problem is that you become less capable of movement. Less muscle means reduced strength and endurance, which leads to less spontaneous physical activity throughout your day. You move less, you fidget less, and you are less likely to take the stairs or walk the longer route. This reduction in overall movement and activity is what actually drives weight regain once you stop the medication, not some massive metabolic slowdown. You have made yourself lighter but also less capable of the physical activity that keeps weight off long-term.
Most GPs are brilliant, dedicated professionals doing their best within a system that gives them very little room. Nutrition, body composition and exercise physiology typically get limited teaching time in medical training, and a standard appointment gives little space to cover them alongside everything else.
Clinical guidance has actually moved to close this gap directly: the American Diabetes Association's updated obesity-treatment standards now specifically recommend counselling people on obesity medication about protein intake and muscle-strengthening activity to help protect against the muscle loss that can come with weight reduction (3). Where that guidance reaches patients in practice is a separate question from whether the drugs, or the doctors prescribing them, are the problem.
Weight loss on the scale is clinically valuable. It just isn't the whole picture — body composition, strength, nutrition and physical function deserve attention too.
If you are taking a GLP-1 drug or considering it, here is what the evidence-backed approach looks like.
Resistance training is the most effective tool available for protecting muscle during a caloric deficit, and it's the piece most people on these medications never get told about. It signals to your body that muscle tissue is worth protecting even as you lose weight — without it, your body has less reason to distinguish between muscle and fat when shedding tissue to match reduced energy intake.
Regular resistance training, progressively challenging the major muscle groups at a level appropriate to your current ability and medical status, is what the evidence supports — not a specific mandatory exercise list. Full-body compound movements like squats, deadlifts, presses and rows are effective examples that load bone as well as muscle, but the principle matters more than the exact menu: consistent training, gradually increasing demand, done well enough to avoid injury. Tracking your strength over time, not just the scale, is worth doing alongside it. Coaching from someone who understands progressive overload and can adjust your programme as your capacity changes is genuinely useful here, particularly while you're in a deficit.
If you are losing weight on a GLP-1 drug, your protein intake is worth paying deliberate attention to — appetite suppression makes it easy to eat less of everything, protein included, and current clinical guidance specifically flags protein sufficiency as something to actively protect during treatment, not leave to chance.
The right amount varies with your body size, age, training, total energy intake and health status — there's no single number that fits everyone. Sports-nutrition and clinical-nutrition literature on protein during GLP-1 treatment commonly discusses intakes upward of about 1.2g per kilogram of bodyweight for appropriate adults without kidney disease (4); where you sit depends on factors an article can't know about you. If you have kidney disease or another condition affecting dietary protein, follow the target your clinician or dietitian has set, not a number from a website.
Most people on these drugs are not eating anywhere near enough, especially given that the drugs suppress appetite and make eating feel like a chore. This is why guided attention helps. Left to your own devices, you will likely eat less of everything, including protein, and some of what you lose will be tissue you'd rather keep.
Prioritise protein at every meal. Eat protein first when appetite is suppressed. Use protein powder if whole food sources are insufficient. Track your intake honestly, at least initially, to understand what adequate protein actually looks like. Do not wing this. If you are going to inject drugs, at least spend five minutes a day logging your intake. Focus on high-quality sources: chicken, fish, eggs, Greek yoghurt, lean beef, tofu, and legumes. Do this, and it will be the last diet you ever do
The number on the scale can't tell you whether you're losing fat, lean mass, or some of both — so it helps to track something else alongside it.
You don't need repeated DEXA scans to do this sensibly. Body weight trend over weeks, not single readings, is a reasonable starting point. Waist or other simple body-composition measures can add useful context. Beyond that, the two that matter most day to day are strength — are your working weights holding up or climbing? — and functional capacity: can you carry your shopping, get out of a chair without using your hands, climb a flight of stairs without getting winded? Training performance and how consistently you're eating enough protein round out the picture.
If you're losing weight but your strength is declining and you're feeling consistently weaker, that's worth addressing — not something to shrug off because the number on the scale is moving the right way.
The drugs help regulate hunger and improve insulin sensitivity. They make fat loss easier. But they do not build muscle. They do not protect bone density. They do not improve your functional capacity. Those outcomes require training, protein, and time.
Real body composition improvement takes months. Six months minimum to see significant, sustainable change. A year or more for dramatic transformation. The drug is a tool. It is not the solution.
Your GP's job is to manage your medical treatment, and that includes following your progress and safety on the medication — that's exactly the conversation to keep having with them, especially about appetite, intake, or any adverse effects. What a standard appointment often doesn't have room for is a detailed body-composition and training plan, which is where the gap tends to open up.
It's worth prioritising strength, function and body composition alongside the number on the scale, not instead of it. Asking how to protect your muscle and bone during weight loss, how much protein makes sense for you, and what training fits alongside your treatment are all reasonable questions — for your GP where they concern your medical care, and for a coach for the training and nutrition side of things.
You need someone who understands body composition, not just weight loss — someone who treats a big drop on the scale that comes with a big drop in strength as worth a closer look, not an automatic win.
You need someone who will programme resistance training specifically for you, correct your technique, adjust your progression, and help you get stronger while the scale drops. Someone who will help you find a sensible protein target for your situation, and help you hit it even when appetite is suppressed.
You need someone who will not celebrate weight loss without asking what was lost. Someone who will track your strength benchmarks and function, and adjust your programme when progress stalls or goes in the wrong direction.
I do not measure success by BMI, and I do not tell you that lighter is always better. I teach you how to build and protect the strength that actually matters, so that when you finish, you are not just thinner; you are more capable and better prepared for the long run. Your progress is measured by strength gained, technique mastered, and habits built that will serve you for years — not by a photo.
This complements your prescribed treatment; it doesn't replace or second-guess it. I am not your prescriber. If you have significant appetite or intake problems, persistent side effects, or any concern about the medication itself, that conversation belongs with the clinician managing your treatment, not with me. My part is the training, the general nutrition habits within my scope, and tracking your strength and progression alongside it. If you have a medical condition that affects your diet, get your nutrition target from your clinician or a dietitian rather than an article.
If you are on a GLP-1 drug and feeling confused or weaker than you'd like while everyone around you celebrates the weight loss, you are not alone — the conversation around these drugs still focuses on the scale far more than on what's happening to the rest of your body.
The drugs work. They help with insulin resistance. They regulate hunger. They make fat loss achievable. With deliberate attention to training and nutrition alongside them, that weight loss can leave you stronger and more capable, not just lighter.
The £50 Strength Diagnostic is where I assess exactly where you are, what you are losing, and what needs to change. One session. No underwear photos. Just an honest assessment of your strength, your technique, and a plan that protects the tissue that actually matters. Book at jamesswift.uk/strengthdiagnosticsession.
If you are not local to Neston, The Digital Rack delivers the training approach remotely: Foundation provides structured programming with monthly load and volume management; Signature adds weekly oversight with video analysis and nutrition oversight. Details at jamesswift.uk/onlinecoaching.
Protect the muscle the drug does not.
The Digital Rack builds the resistance-training framework this article describes, with monthly load and volume management in Foundation and weekly oversight with video analysis in Signature.
